Pharmaceutical Discount Agreements for Vinorelbine

This German (Rheinland-Pfalz, Eisenberg) tender concerns pharmaceutical discount agreements specifically for the chemotherapy drug Vinorelbine. In practical terms, this means contractors (likely pharmaceutical distributors or manufacturers) will be bidding to supply Vinorelbine at discounted rates to the procuring entity. The 'open house' nature suggests a framework agreement where multiple suppliers may be selected, allowing the procuring entity to choose among them based on price and potentially other factors. The lack of a published contract value and CPV codes makes assessing the precise scale difficult. However, given the specific drug and regional focus, the agreement likely covers the drug needs of local hospitals or healthcare providers. The extended deadline (almost two years from publication) suggests a potentially complex application process or a longer-term agreement being sought.